-
effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/www.ncbi.nlm.nih.gov/pubmed
September 23, 2021 - of Telemedicine for Routine Antenatal Care
Research Protocol
August 6, 2021
Breast … Pharmacologic Interventions
Systematic Review
April 15, 2021
Accelerated Partial Breast … Irradiation for Breast Cancer
Key Questions
Draft
April 14, 2021
Improving Pain
-
effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/www.ncbi.nlm.nih.gov
September 23, 2021 - of Telemedicine for Routine Antenatal Care
Research Protocol
August 6, 2021
Breast … Pharmacologic Interventions
Systematic Review
April 15, 2021
Accelerated Partial Breast … Irradiation for Breast Cancer
Key Questions
Draft
April 14, 2021
Improving Pain
-
effectivehealthcare.ahrq.gov/products/insulin-blood-sugar-2010/sites/default/files/pdf
September 23, 2021 - of Telemedicine for Routine Antenatal Care
Research Protocol
August 6, 2021
Breast … Pharmacologic Interventions
Systematic Review
April 15, 2021
Accelerated Partial Breast … Irradiation for Breast Cancer
Key Questions
Draft
April 14, 2021
Improving Pain
-
effectivehealthcare.ahrq.gov/products/dcis-effectiveness/abstract
June 21, 2011 - Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/genitourinary-syndrome-key-questions.pdf
January 01, 2021 - Safety outcomes, adverse
events, adverse systemic
events
Potential Effect Modifiers
• History of breast … anxiety, quality of life, partner satisfaction
Systemic
hormone
levels
KQ3&5: Safety outcomes: breast … cancer, breast cancer recurrence or progression, breast
tenderness, cardiovascular risk, endometrial … Systemic adverse events: chronic pain, CVA (stroke); VTE (DVT); death; hot
flashes; headache; breast … Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-
dependent Breast Cancer:
-
effectivehealthcare.ahrq.gov/products/stakeholders-engagement-others/research
October 13, 2011 - Amy Bonoff is a 14-year breast cancer survivor and an active and experienced National Breast Cancer … the NBCC Quality Care Advocate Advisory Committee, she has participated in the Department of Defense Breast … a recipient of the San Antonio Cancer Symposium Scholarship, 2007, and is a sought-after speaker on breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
July 01, 2012 - PET may play an adjunctive
role to breast examination and
mammography in detecting
breast cancer and … Among individuals with
localized breast cancer,
some may have equivocal
results for HER2 protein … Among patients with a palpable
breast mass or suspicious
mammogram, if FDG PET is
performed before … HER2 Testing to Manage Patients With
Breast Cancer or Other Solid Tumors. … Should FDG PET be used to decide whether a
patient with an abnormal mammogram or
breast finding at
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
March 05, 2015 - Some of the trials including breast
cancer patients also included patients who did not have breast … However, hot
flushes among breast cancer survivors can be more
frequent and more severe. … , and saying the
report excluded studies in breast cancer survivors. … for women with and without breast cancer. … See “Executive Summary” comment #3 regarding
exclusion of women with breast cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-key-question.pdf
September 18, 2023 - are only four cancers recommended for screening by the US Preventive
Services Task Force (USPSTF; breast … An economic model
published in August 2023 found that USPSTF-recommended cancer screenings for breast … Cancers with gold standard and routine screening modalities (i.e., breast, cervical, and
colon cancers … Role of ctDNA in breast cancer. Cancers.
2022;14(2):310.
7.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - outcomes, overall 5-year
survival is only 42 percent for ovarian cancer
compared with 88 percent for breast … 3
KQ 5: What are the harms of OC use, including
breast cancer incidence, cervical cancer incidence … Analytic framework for systematic review
BRCA = breast cancer genetic mutation; KQ = Key Question; OC … Harms of OC Use
Breast Cancer
Table E shows the strength of evidence for the effect of OC
use on breast … Ever use of OCs is associated with a
small but significant increase in breast cancer risk, based
on
-
effectivehealthcare.ahrq.gov/sites/default/files/hawley-presentation.pdf
November 11, 2015 - now for decades
-- that African-American women tend to be diagnosed with later stages of breast … The next two studies are more my area of breast
cancer research. … This slide for
colorectal cancer patients and the next for breast cancer patients, show responses … In this
study we asked patients, after they had completed their breast cancer treatment,
"How … We were able to examine this in our breast cancer sample.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
January 01, 2020 - ” in contrast to those fed
expressed breast milk. … For overall breast cancer, there was only 1 recent SR. … Summary of key findings for Breast
cancer, and related tables. … For overall breast cancer, there was only 1 recent SR. … milk from the breast,
even one time.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gaps-womens-health-22.pdf
April 01, 2022 - mastectomy for breast cancer
(or breast cancer prophylaxis). … AR) is probably
associated with clinically better sexual well-being
and patient satisfaction with breasts … IBR may also pose
a greater risk of breast seroma. … • Silicone or saline implants may result in clinically
comparable patient satisfaction with breasts … perforator
(DIEP) or latissimus dorsi (LD) flaps may result in
comparable patient satisfaction with breasts
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/
August 23, 2021 - Therapy for Bone Metastases
Submitted: July 17, 2020
Accelerated Partial Breast … Irradiation for Breast Cancer
Submitted: July 17, 2020
Impact of Insurance
-
effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
October 01, 2007 - Benign breast disease—the risks of commu-
nicating risk �comments�. … Collaborative Group on Hormonal Factors in Breast Cancer. … studies of 52,705 women with breast
cancer and 108,411 women without breast cancer. … The small risk of breast
cancer and possible cardiovascular problems? … She was not
happy with the risk of breast cancer, but it sounded small.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
June 12, 2013 - Women with breast cancer are excluded. … The issue of tamoxifen use was raised with respect to women with breast cancer. … Given that women with breast cancer are not an included population, this was not further
Source: … Given the natural history of osteoporosis—as well as breast, ovarian, and colorectal cancer—
a minimum … Women with
breast cancer are excluded.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
January 01, 2009 - Example: MRI as an add-on test for staging early breast cancer
Breast MRI is proposed to detect additional … for
breast-conserving surgery (BCS) (Table 1). … These concepts can be applied to the breast MRI example. … Early Breast Cancer Trialists'
Collaborative Group. … Standard for breast conservation
therapy in the management of
invasive breast carcinoma.
-
effectivehealthcare.ahrq.gov/products/menopause/research-protocol
April 03, 2012 - Women with breast cancer are excluded. … The issue of tamoxifen use was raised with respect to women with breast cancer. … Given that women with breast cancer are not an included population, this was not further considered. … Given the natural history of osteoporosis—as well as breast, ovarian, and colorectal cancer—a minimum … Women with breast cancer are excluded.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - Women with breast cancer are excluded. … The issue of tamoxifen use was raised with respect to women with breast cancer. … Given that women with breast cancer are not an included population, this was not further
considered. … Given the natural history of osteoporosis—as well as breast, ovarian, and colorectal cancer—
a minimum … Women with
breast cancer are excluded.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-frameworks.ppt
June 01, 2012 - HER2 testing to manage patients with breast cancer or other solid tumors. … HER2 testing to manage patients with breast cancer or other solid tumors. … HER2 testing to manage patients with breast cancer or other solid tumors. … HER2 testing to manage patients with breast cancer or other solid tumors. … HER2 testing to manage patients with breast cancer or other solid tumors.